CNS Pharmaceuticals, Inc. (CNSP) › Shares OutstandingCNS Pharmaceuticals, Inc. (CNSP) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2018: 12.69M2019: 16.45M2020: 23.86M2021: 949.1K2022: 1.62M2023: 2.5K2024: 117.8K2025: 632.5K632.5K2018Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025632.5K+437.0%2024117.8K+4638.4%20232.5K-99.8%20221.62M+70.4%2021949.1K-96.0%202023.86M+45.0%201916.45M+29.6%201812.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share